Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$427M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 3 |
STJ
St Jude Medical
STJ
|
+$235M |
| 4 |
JPMorgan Chase
JPM
|
+$211M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
PUT
HSBC
HSBC
$352B
| $26.6M | 0.03% |
720,655
+589,254
| +448% | +$22.1M |
|
452
Salesforce
CRM
$158B
| $26.5M | 0.03% |
320,813
-616,868
| -66% | -$49.3M |
|
|
ATVI
453
DELISTED
Activision Blizzard
ATVI
| $26.4M | 0.03% |
529,120
-368,420
| -41% | -$16.2M |
|
454
Regeneron Pharmaceuticals
REGN
$79.1B
| $26.4M | 0.03% |
68,035
-31,750
| -32% | -$11.8M |
|
|
NE
455
DELISTED
Noble Corporation
NE
| $26.1M | 0.03% |
4,223,134
+3,908,465
| +1,242% | +$26.3M |
|
456
CALL
Mastercard
MA
$500B
| $26.1M | 0.03% |
232,400
-111,300
| -32% | -$12.2M |
|
|
PARA
457
DELISTED
Paramount Global Class B
PARA
| $26.1M | 0.03% |
376,040
-5,653
| -1% | -$371K |
|
|
SHPG
458
DELISTED
Shire pic
SHPG
| $26M | 0.03% |
149,495
+60,566
| +68% | +$10.6M |
|
459
BioMarin Pharmaceuticals
BMRN
$11.6B
| $26M | 0.03% |
296,692
-7,632
| -3% | -$679K |
|
460
WEC Energy
WEC
$35.3B
| $26M | 0.03% |
429,259
+148,191
| +53% | +$8.73M |
|
461
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $25.8M | 0.03% |
293,800
-306,200
| -51% | -$26.7M |
|
462
Illumina
ILMN
$30.2B
| $25.7M | 0.03% |
155,010
-217,344
| -58% | -$34.2M |
|
463
PUT
Johnson & Johnson
JNJ
$621B
| $25.7M | 0.03% |
206,500
-2,403,700
| -92% | -$287M |
|
464
Northern Trust
NTRS
$33.7B
| $25.7M | 0.03% |
296,453
+171,383
| +137% | +$14.9M |
|
465
PUT
Qualcomm
QCOM
$165B
| $25.5M | 0.03% |
444,500
-40,600
| -8% | -$2.36M |
|
466
Hewlett Packard
HPE
$70.5B
| $25.4M | 0.03% |
1,844,367
+180,211
| +11% | +$2.42M |
|
|
PX
467
DELISTED
Praxair Inc
PX
| $25.3M | 0.03% |
213,121
+744
| +0.4% | +$87.5K |
|
468
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.99B
| $25.2M | 0.03% |
363,500
+104,300
| +40% | +$7M |
|
469
CALL
Energy Transfer Partners
ET
$70B
| $25.2M | 0.03% |
1,275,200
+775,600
| +155% | +$14.6M |
|
470
PUT
Vertex Pharmaceuticals
VRTX
$123B
| $25.1M | 0.03% |
229,800
+156,900
| +215% | +$13.8M |
|
471
InterDigital
IDCC
$8.53B
| $25.1M | 0.03% |
290,601
-31,622
| -10% | -$2.84M |
|
|
TWTR
472
DELISTED
Twitter, Inc.
TWTR
| $25.1M | 0.03% |
1,676,678
-1,039,276
| -38% | -$16.9M |
|
473
PUT
Banco Santander
SAN
$209B
| $25M | 0.03% |
4,304,765
-2,768,348
| -39% | -$14.9M |
|
474
State Street SPDR S&P Regional Banking ETF
KRE
$4.71B
| $25M | 0.03% |
457,658
+318,143
| +228% | +$17.8M |
|
|
FISV
475
Fiserv Inc
FISV
$28.9B
| $24.9M | 0.03% |
431,056
+35,316
| +9% | +$1.98M |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.